[e-drug] AstraZeneca launched new 'Patient Assistance Program' (2)

["Murat Civaner" <mcivaner@gmail.com>]

E-DRUG: AstraZeneca launched new 'Patient Assistance Program' (2)
----------------------------------------------------

Reasons 2,3 and 4 make sense. But my favourite is the last one: These sorts
of programmes are actually cost-effective for the company. Otherwise they
wouldn t be accountable to their shareholders. This explanation fits nicely
for every move of companies.

Maybe I can add that:

- It is a variation of giving drug samples to prescribers as a marketing
method. 
- It is a supportive move for DTC.
- It will be useful for their stock (to be able produce and sale on a
constant level)

Murat

---------------------------------
Murat Civaner. MD PhD
Dokuz Eylul University
School of Medicine
Dept. of Medical Ethics,
Izmir, Turkey
+90.232.412 4001
mcivaner@gmail.com